| Antigen: |
Plasminogen |
| Relevance: |
Plasminogen is converted to the active serine protease plasmin by proteolytic cleavage by urokinase-type (uPA) and tissue-type (tPA) plasminogen activators. Plasmin is a key enzyme in the fibrinolytic pathway (lysis of the unwanted blood clots). |
| Clone: |
SBF1 C1.21 |
| Subclass: |
IgG1 |
| Applications: |
ELISA |
| Immunogen: |
Human Plasminogen |
| Reactivity: |
Human |
| Species raised in: |
Mouse |
| Fusion partner: |
NS0 |
| Recommended growth conditions: |
DMEM 5% FCS |
| References: |
- |
| Notes: |
Cross reacts with plasmin, but not with HGF1/MSP or HGF/SF |
For further information about antibodies from CRT or to discuss sales or licensing options, please contact us at reagents@cancertechnology.com
Please note that CRT supplies to distributors only. However, we are happy to direct researchers to the appropriate commercial party to obtain antibodies within our portfolio. Click here to view disclaimer information. |
